Ultimately, TRPV1 clearly plays a central role in the pathology of OA, RA, and gout, with a variety of studies indicating that the activation of TRPV1 leads to the release of inflammatory compounds that initiate and potentiate the disease process, while also serving as a target of many of these same molecules (Figure 1). The gene discussed is TRPV1; the disease is gout.